The First $100 Billion Drug
Jp Vanzyl
22 min
Business & Finance
Description
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time. Learn more about your ad choices. Visit megaphone.fm/adchoices
Uploader
trent.drop
Episodes
1
The First $100 Billion Drug
Jp Vanzyl